Detalhe da pesquisa
1.
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug Resistance.
Cancers (Basel)
; 15(3)2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765949
2.
The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
J Exp Clin Cancer Res
; 41(1): 160, 2022 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490242
3.
A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Cancer Res
; 79(24): 6166-6177, 2019 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615807
4.
Molecular imaging of neuroblastoma progression in TH-MYCN transgenic mice.
Mol Imaging Biol
; 15(2): 194-202, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777578